Skip to content

Opening book details…

About this Economics, Econometrics and Finance article

Pcn11 Cost-utility Analysis Of Dasatinib In Patients After First-line Failure Of Imatinib In Chronic Myeloid Leukemia (cml) In Austria by JFS Logman; MJ Taylor; K Neumann; L Kutikova; KH Cerri; BA Van Hout; T Kühr is a Economics, Econometrics and Finance article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Economics, Econometrics and Finance.

Author
JFS Logman; MJ Taylor; K Neumann; L Kutikova; KH Cerri; BA Van Hout; T Kühr
Publisher
John Wiley and Sons; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1098-3015)
Published
2007
Field
Economics, Econometrics and Finance (Social Sciences)

More by JFS Logman; MJ Taylor; K Neumann; L Kutikova; KH Cerri; BA Van Hout; T Kühr

Browse all works by JFS Logman; MJ Taylor; K Neumann; L Kutikova; KH Cerri; BA Van Hout; T Kühr